(Q43059203)

13 November 2017

title

Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome? (English)

1 reference

13 November 2017

T van Gelder

1

1 reference

13 November 2017

D A Hesselink

series ordinal

2

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Clinical Pharmacology & Therapeutics

13 November 2017

published in

1 reference

13 November 2017

volume

87

1 reference

13 November 2017

issue

6

1 reference

13 November 2017

page(s)

640-641

1 reference

Immunosuppression: evolution in practice and trends, 1994-2004.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.42

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.42

1 reference

13 November 2017

1 reference